Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tycoon Group Holdings Limited is a leading provider of health and anti-aging products, specializing in distribution and brand management within the Greater China region. The company operates a robust multi-channel distribution network that includes wholesale to major retail chains, e-commerce platforms, and its own retail outlets. Its extensive product portfolio features a mix of third-party brands and proprietary labels, spanning traditional Chinese medicine, health supplements, and personal care items. Tycoon Group maintains a strategic partnership with China Resources Pharmaceutical Group, which serves as a major shareholder and supply chain collaborator. The company is headquartered in Hong Kong and has expanded its footprint into Macau, mainland China, and Southeast Asia to capitalize on growing wellness trends. As a publicly traded entity on the Hong Kong Stock Exchange, it focuses on scaling its digital presence and diversifying its product offerings to meet consumer demand for high-quality healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tycoon Group.